Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Mayo Clinic Ovarian Cancer SPORE
Kaufmann, S. H., Bell, D. A., Bible, K. C., Cliby, W. A., Couch, F. J., Fields, A. P., Galanis, E., Goode, E. L., Haluska, P. R. J., Hartmann, L. C., Karnitz, L. M., Keeney, G., Knutson, K. L., Lengyel, E., Lingle, W. L., Long, H. J., Sherman, M., Moriarity, B. S., Oberg, A. L., Peng, K., Shridhar, V. & Weroha, S.
9/1/09 → 8/31/24
Project: Research project
-
Project 3: Repurposing Ceritinib for Ovarian Cancer Therapy
Karnitz, L. M. & Karnitz, L. L. M.
9/1/21 → 8/31/23
Project: Research project
-
-
Analysis of a DNA Damage-Inducible Checkpoint Complex
Karnitz, L. M. & Karnitz, L. M.
7/1/00 → 6/30/09
Project: Research project
-
-
DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancer
Chowdhury, S., Wang, R., Yu, Q., Huntoon, C. J., Karnitz, L. M., Kaufmann, S. H., Gygi, S. P., Birrer, M. J., Paulovich, A. G., Peng, J. & Wang, P., Dec 2022, In: BMC bioinformatics. 23, 1, 321.Research output: Contribution to journal › Article › peer-review
Open Access -
Intra-S phase checkpoint kinase Chk1 dissociates replication proteins Treslin and TopBP1 through multiple mechanisms during replication stress
Kelly, R. L., Huehls, A. M., Venkatachalam, A., Huntoon, C. J., Machida, Y. J. & Karnitz, L. M., Apr 1 2022, In: Journal of Biological Chemistry. 298, 4, 101777.Research output: Contribution to journal › Article › peer-review
Open Access -
Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma
Kanakkanthara, A., Hou, X., Ekstrom, T. L., Zanfagnin, V., Huehls, A. M., Kelly, R. L., Ding, H., Larson, M. C., Vasmatzis, G., Oberg, A. L., Kaufmann, S. H., Mansfield, A. S., Weroha, S. J. & Karnitz, L. M., Jan 15 2022, In: Cancer research. 82, 2, p. 307-319 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
CDK2-mediated upregulation of TNFa as a mechanism of selective cytotoxicity in acute leukemia
Ding, H., Vincelette, N. D., McGehee, C. D., Kohorst, M. A., Koh, B. D., Venkatachalam, A., Wei Meng, X., Schneider, P. A., Flatten, K. S., Peterson, K. L., Correia, C., Lee, S. H., Patnaik, M., Webster, J. A., Ghiaur, G., Douglas Smith, B., Karp, J. E., Pratz, K. W., Li, H., Karnitz, L. M., & 1 others , May 2021, In: Cancer research. 81, 10, p. 2666-2678 13 p.Research output: Contribution to journal › Article › peer-review
-
Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
Hurley, R. M., McGehee, C. D., Nesic, K., Correia, C., Weiskittel, T. M., Kelly, R. L., Venkatachalam, A., Hou, X., Pathoulas, N. M., Meng, X. W., Kondrashova, O., Radke, M. R., Schneider, P. A., Flatten, K. S., Peterson, K. L., Becker, M. A., Wong, E. M., Southey, M. S., Dobrovic, A., Lin, K. K., & 13 others , Sep 1 2021, In: NAR Cancer. 3, 3, zcab028.Research output: Contribution to journal › Article › peer-review
Open Access